Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
Titel:
Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
Auteur:
Dupuis, Jehan Bachy, Emmanuel Morschhauser, Franck Cartron, Guillaume Fukuhara, Noriko Daguindau, Nicolas Casasnovas, René-Olivier Snauwaert, Sylvia Gressin, Remy Fox, Christopher P d’Amore, Francesco Annibale Staber, Philipp B Tournilhac, Olivier Bouabdallah, Krimo Thieblemont, Catherine André, Marc Rai, Shinya Ennishi, Daisuke Gkasiamis, Argyrios Nishio, Mitsufumi Fornecker, Luc-Matthieu Delfau-Larue, Marie-Helene Sako, Nouhoum Mule, Sebastien de Leval, Laurence Gaulard, Philippe Tsukasaki, Kunihiro Lemonnier, François